Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 02 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

This vaccine aligns with the World Health Organization's recommendations for the upcoming flu season, addressing a significant global health concern. The launch aims to improve preventive health measures against seasonal influenza, particularly for vulnerable populations. Dr. Sharvil Patel emphasized the importance of timely access to vaccines to reduce vaccine-preventable diseases.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 02, 2025, titled "Zydus launches VaxiFluTM India s first trivalent influenza vaccine for flu protection".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases